Search hospitals > Michigan > Grand Rapids
Mercy Health Saint Mary's
Claim this profileGrand Rapids, Michigan 49503
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Ovarian Cancer
306 reported clinical trials
3 medical researchers
Summary
Mercy Health Saint Mary's is a medical facility located in Grand Rapids, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Ovarian Cancer and other specialties. Mercy Health Saint Mary's is involved with conducting 306 clinical trials across 459 conditions. There are 3 research doctors associated with this hospital, such as Kathleen J. Yost, Muhammad Farooq, and Jason Bennett.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Kathleen J. YostBronson Methodist Hospital8 years of reported clinical research
Expert in Cancer
Expert in Brain Tumor
233 reported clinical trials
343 drugs studied
Muhammad FarooqTrinity Health Saint Mary's5 years of reported clinical research
Studies Stroke
Studies Atrial Fibrillation
4 reported clinical trials
8 drugs studied
Jason BennettMercy Health Saint Mary's3 years of reported clinical research
Studies Overactive Bladder
1 reported clinical trial
1 drug studied
Clinical Trials running at Mercy Health Saint Mary's
Lung Cancer
Breast Cancer
Breast cancer
Pancreatic Cancer
Cancer
Colorectal Cancer
Melanoma
Bladder Cancer
Ovarian Cancer
Cutaneous Melanoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Thoracotomy vs Thoracoscopy
for Metastatic Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting2 awards Phase 37 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Mercy Health Saint Mary's?
Mercy Health Saint Mary's is a medical facility located in Grand Rapids, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Ovarian Cancer and other specialties. Mercy Health Saint Mary's is involved with conducting 306 clinical trials across 459 conditions. There are 3 research doctors associated with this hospital, such as Kathleen J. Yost, Muhammad Farooq, and Jason Bennett.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.